Yabao Pharmaceutical Group Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yabao Pharmaceutical Group Company Limited with three other
companies in this sector in China:
Zhejiang Jianfeng Group Company Limited
sales of 2.26 billion Chinese Renmimbi [US$328.03 million]
of which 45%
PKU HealthCare Corp Ltd
(2.01 billion Chinese Renmimbi [US$292.11 million]
of which 63%
was Merchandise&Material Selling), and
Shanxi Zhendong Pharmaceutical Co Ltd
(2.26 billion Chinese Renmimbi [US$328.64 million]
of which 95%
was Medicine Manufacture and Sale).
Yabao Pharmaceutical Group Company Limited reported sales of 2.07 billion Chinese Renmimbi (US$300.04 million)
December of 2015.
increase of 9.3%
versus 2014, when the company's sales were 1.89 billion Chinese Renmimbi.
This was the third consecutive year of growth at Yabao Pharmaceutical Group Company Limited.
Sales of Other Operations saw an increase
that was more than double the company's growth rate: sales were up
80.8% in 2015, from
6.98 million Chinese Renmimbi to 12.62 million Chinese Renmimbi.
Yabao Pharmaceutical Group Company Limited also saw significant increases in sales in
Pharmaceutical Wholesale (up 66.4% to 395.12 million Chinese Renmimbi)
Not all segments of Yabao Pharmaceutical Group Company Limited experienced an increase in sales in 2015:
sales of Other fell 69.1% to 10.48 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).